🇺🇸 FDA

Drug profile · INN

fluticasone furoate

ARNUITY ELLIPTA

FDA: approved EMA: approved TGA: approved R03AL08
US status
approved
Patents linked
0
News articles
0

Quick answer

fluticasone furoate (ARNUITY ELLIPTA) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline. Route of administration: nasal. Current US regulatory status: approved.

Key facts

INN fluticasone furoate
Brand ARNUITY ELLIPTA
Route NASAL
Formulation POWDER
ATC code R03AL08
Originator GlaxoSmithKline

Frequently asked questions

What is fluticasone furoate?

fluticasone furoate (ARNUITY ELLIPTA) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline. Route of administration: nasal. Current US regulatory status: approved.

What is the brand name for fluticasone furoate?

ARNUITY ELLIPTA is a marketed brand name for fluticasone furoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluticasone furoate?

fluticasone furoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.